Sage Journals: Discover world-class research

Open access

Research article

First published 2020

A phase II study of liposomal irinotecan with 5-fluorouracil,leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial

Francesca Simionato, Camilla Zecchetto, Valeria Merz [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium

Lise Verbruggen, Lisa Verheggen, Greetje Vanhoutte [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study

Wei-Ze Wong, Nai-Jung Chiang, Kuei-Chuan Lee [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain

Rafael Álvarez-Gallego, Roberto Pazo-Cid, Borja López de San Vicente [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Effectiveness and cost analysis of liposomal irinotecan in patients with pancreatic adenocarcinoma: a multicenter real-world study

Jung Won Chun, Young Ae Kim, Jang Won Lee [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma

Jung Won Chun, Sang Myung Woo, Sang Hyub Lee [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study

Jiyoung Keum, Hee Seung Lee, Chan Su Park [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study

Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Real-world outcomes of fluorouracil-based second-line therapy in patients with advanced biliary tract cancer refractory to gemcitabine and cisplatin-based treatment

Se Jun Park, Kabsoo Shin, Hyunho Kim [...]

Therapeutic Advances in Medical Oncology

Search results